v3.26.1
Cover - $ / shares
6 Months Ended
Jun. 30, 2026
Aug. 10, 2026
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2026  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2026  
Current Fiscal Year End Date --12-31  
Entity File Number 001-40789  
Entity Registrant Name Calidi Biotherapeutics, Inc.  
Entity Central Index Key 0001855485  
Entity Tax Identification Number 86-2967193  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 4475 Executive Drive  
Entity Address, Address Line Two Suite 200  
Entity Address, City or Town San Diego  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92121  
City Area Code (858)  
Local Phone Number 794-9600  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol CLDI  
Security Exchange Name NYSEAMER  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,584,184
Entity Listing, Par Value Per Share $ 0.0001